Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Necrosis01:16

Necrosis

6.3K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Allosteric Regulation01:08

Allosteric Regulation

62.9K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
62.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

TRIM28 Is an E3 Ligase of IRP2 Suppressing Ischemia/Reperfusion-Induced Myocardial Ferroptosis.

Circulation·2026
Same author

Structural basis of BAX pore formation.

Science (New York, N.Y.)·2025
Same author

Therapeutic Reprogramming toward Regenerative Medicine.

Chemical reviews·2025
Same author

Pharmacologically inducing regenerative cardiac cells by small molecule drugs.

eLife·2024
Same author

Synovial sarcoma X breakpoint 1 protein uses a cryptic groove to selectively recognize H2AK119Ub nucleosomes.

Nature structural & molecular biology·2024
Same author

Structural insights into CED-3 activation.

Life science alliance·2023

相关实验视频

Updated: Jan 11, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K

通过ALDOA介导的代谢重编程是癌症中对铁死敏感化的可针对性脆弱性.

Pengqi Wang1, Kezhang He1, Bowen Wang1

  • 1New Cornerstone Science Laboratory, School of Pharmaceutical Sciences, Tsinghua University, Beijing, 100084, China.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|November 12, 2025
PubMed
概括
此摘要是机器生成的。

阿尔多酶A (ALDOA) 重新编程癌细胞代谢以抵抗铁灭. 抑制ALDOA或使用ALDOA抑制剂可以选择性地使癌细胞对ferroptosis敏感,从而提供了向的癌症治疗方法.

关键词:
阿尔多阿阿尔多阿阿尔多阿自自是自的过程.癌症 癌症 癌症 癌症 癌症铁性化 (ferroptosis) 是一种脂质新陈代谢 脂质新陈代谢代谢重编程是指代谢重编程.

相关实验视频

Last Updated: Jan 11, 2026

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.8K

科学领域:

  • 生物化学 生物化学
  • 分子生物学分子生物学
  • 癌症研究 癌症研究

背景情况:

  • 铁化是一种有前途的癌症治疗策略.
  • 非选择性铁灭症诱导由于对正常细胞的影响,限制了治疗疗效.

研究的目的:

  • 在癌症中确定选择性铁亡诱导的新目标.
  • 研究阿尔多酶A (ALDOA) 在铁灭症耐药性中的作用.

主要方法:

  • 代谢分析的代谢分析
  • 自的测定测试.
  • 在体外和体外癌细胞模型.
  • 关于ALDOA抑制的研究.

主要成果:

  • 阿尔多酶A (ALDOA) 重新编程脂质新陈代谢,使癌细胞具有对铁亡的抵抗力.
  • 抑制或抑制ALDOA会增加癌细胞对铁亡的敏感性.
  • ALDOA的枯竭导致果糖1,6-双酸盐的积累,并增强了脂质修饰酶的自依赖性降解.
  • 阿尔多阿抑制剂在体外和体内都可选择性地诱导癌细胞中的铁亡.

结论:

  • 阿尔多酶A (ALDOA) 是代谢重编程的关键媒介,使得癌症对铁亡产生抵抗力.
  • 向ALDOA代表了在癌症治疗中选择性铁亡敏感化的可行策略.